-
Sartorius Supports Development of Vaccine Candidate against Coronavirus
americanpharmaceuticalreview
March 30, 2020
Sartorius has supported CanSino Biologics and Maj. Gen. Chen Wei’s team at the Institute of Bioengineering at the Academy of Military Medical Sciences ...
-
Sartorius Supports Coronavirus Vax Candidate
contractpharma
March 26, 2020
BIOSTAT STR single-use bioreactor system used for the upstream preparation of the recombinant vaccine.
-
Sartorius Supports the Development of the First Vaccine Candidate Against the Novel Coronavirus to Enter Clinical Trials
.b3cnewswire
March 25, 2020
CanSinoBIO and the Institute of Bioengineering used Sartorius’ BIOSTAT® STR single-use bioreactor system for the upstream preparation of the recombinant vaccine, thus ensuring the rapid linear amplification of the adenovirus vector (Ad5-nCoV) and ultimate
-
European and U.S. Antitrust Authorities Clear Acquisition of Select Danaher Life Science Businesses by Sartorius
prnasia
March 20, 2020
The businesses to be acquired are part of Danaher's Life Sciences platform and include various laboratory and bioprocessing technologies that are complementary to the portfolios of both Sartorius divisions.
-
Sartorius Launches BIOSTAT STR® Generation 3 with BIOBRAIN - Making Biopharmaceutical Development and Production Faster, Simpler and Safer
b3cnewswire
March 12, 2020
Engineered to address the rigorous requirements and complexity of biologics manufacture, Sartorius’ BIOSTAT STR® Generation 3 single-use bioreactor and BIOBRAIN automation platform introduce innovations that will change the field of biopharmaceutical proc
-
Sartorius Introduces BioPAT® Spectro to Enable Raman Spectroscopy Capability and QbD with its ambr® and BIOSTAT STR® Platforms
prnasia
March 02, 2020
Sartorius, a leading international partner of the biopharmaceutical industry today introduced BioPAT® Spectro, a Quality by Design (QbD) tool for use with its ambr® automated micro and mini bioreactor systems and with the single-use production bioreactors
-
Sartorius and the German Research Center for Artificial Intelligence Launch Joint Research Laboratory
b3cnewswire
December 25, 2019
Sartorius, a leading international partner of life science research and the biopharmaceutical industry, and the German Research Center for Artificial Intelligence (DFKI) have established the Sartorius AI Lab (SAIL) research laboratory.
-
Sartorius Establishes Scientific Advisory Board
b3cnewswire
December 25, 2019
Sartorius, a leading international partner of life science research and the biopharmaceutical industry, today announced that it established a Scientific Advisory Board for its Corporate Research activities.
-
Sartorius, German Research Center for AI Launch Joint Research Laboratory
americanpharmaceuticalreview
December 20, 2019
Sartorius and the German Research Center for Artificial Intelligence (DFKI) have established the Sartorius AI Lab (SAIL) research laboratory.
-
Sartorius Expands Cell Culture Media Capabilities
contractpharma
December 12, 2019
Sartorius has signed an agreement to acquire a majority stake in the Israeli cell culture media developer and manufacturer Biological Industries.